Infection Leading Articles & Analysis
64 news found
Analysis by Airfinity shows between 1.3 and 2.1 million lives could be at risk if China lifts its zero-COVID policy given low vaccination and booster rates as well as a lack of hybrid immunity. Airfinity’s risk analysis uses cumulative peak cases and deaths from Hong Kong's BA.1 wave as a proxy for mainland China. Hong Kong took a zero-COVID approach for the first two years of the ...
Sepsis is the body’s over active and toxic response to an infection that causes hospitalization of more than 18 million people around the world every year, including 30,000 Canadians Declared a Global Health Priority by the World Health Organization in 2017 80% of sepsis deaths in hospitals could be prevented with rapid diagnosis and treatment Vancouver, Canada: ...
About Hepatitis B Hepatitis B is one of the world’s most significant infectious disease threats with more than 290 million people infected globally. HBV infection is the leading cause of liver disease and, with current treatments, it is very difficult to cure, with many patients going on to develop liver cancers. ...
aureus is the primary pathogen associated with surgical site infections (SSIs).[i] No reportable adverse events. Ondine Biomedical Inc. ...
There are over 250 million people who suffer from lower respiratory tract infections (LTRI) every year and it is the 5th leading cause of death globally. The COVID-19 pandemic has highlighted the urgency for effective respiratory therapies. Inhaled anti-infectives dramatically improve the targeting of therapies to the site of respiratory ...
Dillman was also responsible for all segment, consumer, and digital marketing activities, and spent three years as the General Manager of VaxServe, a Sanofi Pasteur company and a leading specialty distributor of vaccines. About Hepatitis B Hepatitis B is one of the world’s most significant infectious disease threats with more than 290 million people ...
About Hepatitis B Hepatitis B is one of the world’s most significant infectious disease threats with more than 290 million people infected globally. HBV infection is the leading cause of liver disease and, with current treatments, it is very difficult to cure, with many patients going on to develop liver cancers. ...
(Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation for PreHevbri™ [Hepatitis B vaccine (recombinant, adsorbed)] for active immunisation against infection caused by all ...
Oral Presentation Details Abstract Number: 1416 Title: Long term persistence of Anti-HBs antibodies after vaccination with a 3-antigen HBV vaccine compared to a single-antigen HBV vaccine Session: Viral hepatitis B/D: Clinical aspects except therapy Date: Sunday, June 26, 2022 Time: 10:00-11:30 AM BST Presenter: Timo Vesikari, M.D., Ph.D., Professor Emeritus and Director of the Nordic ...
For patients undergoing peritoneal dialysis (PD), rates of infection-driven hospitalization are as high as 0.5 hospitalizations per patient year, according to the U.S. ...
If left untreated, lymphedema can become a chronic lifelong condition leading to life-threatening infections and a significant reduction in the patient’s quality of life. ...
FDA Orphan Drug Designation (ODD) underscores strength of Atriva’s pipeline and high need for treatments for rare and neglected tropical diseases ODD allows Atriva to benefit from various incentives to develop zapnometinib (ATR-002) against hantavirus infections, and may result in seven-year market exclusivity on approval for this indication Targeting RNA viruses like ...
CpG 1018 Adjuvanted Shingles (Herpes Zoster) Vaccine Candidate Enters the Clinic Shingles is an extremely painful consequence of the reactivation of a latent varicella zoster virus infection, with attacks leading to potential complications including chronic pain. ...
Food and Drug Administration (FDA) has granted its lead multi-virus specific T cell (VST) therapy, posoleucel (Viralym-M, ALVR105), Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of adenovirus (AdV) infection following allogeneic hematopoietic stem cell transplant (allo-HCT). ...
ByKalaris
The study demonstrated the test’s high performance in distinguishing between bacterial and viral infection Incorporated a broad pediatric population presenting with fever without source and respiratory tract infection MeMed’s test outperformed existing biomarkers of infection MeMed, a leader in the emerging field of advanced ...
ByMeMed
She has a specialist interest in complex lung infection and is the clinical lead for the South Manchester Bronchiectasis Service. ...
It is the most prevalent parasitic disease in the western hemisphere, infecting 6-7 million people with over 70 million at risk. Moreover, CDC estimates approximately 300,000 cases in the U.S., principally among individuals who acquired it in endemic countries, although some autochthonous infections have also been reported. Chagas can also be transmitted ...
NHT focuses on creating effective inhalation therapies to address lower respiratory tract infections (the 5th leading overall cause of death worldwide) and other deadly lung diseases. ...
Over time, the sinuses can become infected leading to inflammation and pain. Up to 60% of CRS patients may not experience significant improvements in their symptoms despite trying multiple over the counter and prescription medications. ...
Roden — July 7, 2021 — Mycobacterium abscessus is a nontuberculous mycobacterium (NTM) that primarily causes severe pulmonary infections. The pathogen is also known as the ‘antibiotic nightmare’, due to its resistance to nearly all antibiotics. ...